Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability

11 organizations filed 13 public comments on Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 3080d ago.

Commenters (11)

• National Consumers Leaguetrade assoc.

  2 filings · confidence 85%
• National Home Infusion Associationtrade assoc.

  2 filings · confidence 85%
• & Jacobs Institute of Women's Healthtrade assoc.

  1 filing · confidence 85%
• American Academy of Dermatology Associationtrade assoc.

  1 filing · confidence 85%
• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• American Society of Anesthesiologiststrade assoc.

  1 filing · confidence 85%
• California Life Sciences Associationtrade assoc.

  1 filing · confidence 85%
• HealthCare Institute of New Jerseytrade assoc.

  1 filing · confidence 85%
• National Association of Chain Drug Storestrade assoc.

  1 filing · confidence 97%
• National Community Pharmacists Associationtrade assoc.

  1 filing · confidence 97%
• Texas Healthcare & Bioscience Institutetrade assoc.

  1 filing · confidence 85%